Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Abstract The most successful immunotherapies for solid malignancies to date, immune checkpoint inhibitors, target the essential role of T cells in antitumor immunity. However, T‐cell dysfunction presents a major hindrance to treatment efficacy, warranting research into combined treatment strategies...
Saved in:
| Main Authors: | Faith Hartley, Martin Ebert, Alistair M Cook |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical & Translational Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cti2.70030 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Modulation Through Stereotactic Radiotherapy: The Role of TBX21, GATA-3, FoxP3, and RORɣt
by: Aybala Nur Ucgul, et al.
Published: (2025-04-01) -
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases
by: Meichen Li, et al.
Published: (2024-12-01) -
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01) -
Spatial genomics uncovers cytokines promoting ovarian tumour heterogeneity and immunotherapy resistance
by: Gurkan Mollaoglu, et al.
Published: (2025-02-01) -
Immunological biomarkers and gene signatures predictive of radiotherapy resistance in non-small cell lung cancer
by: Jie Lv, et al.
Published: (2025-05-01)